These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11003254)

  • 1. Use and interpretation of HbA1c testing in general practice. Implications for quality of care.
    Skeie S; Thue G; Sandberg S
    Scand J Clin Lab Invest; 2000 Aug; 60(5):349-56. PubMed ID: 11003254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Availability and analytical quality of hemoglobin A1c point-of-care testing in general practitioners' offices are associated with better glycemic control in type 2 diabetes.
    Tollånes MC; Jenum AK; Berg TJ; Løvaas KF; Cooper JG; Sandberg S
    Clin Chem Lab Med; 2020 Jul; 58(8):1349-1356. PubMed ID: 32229656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Afinion HbA1c measurements in general practice as judged by external quality assurance data.
    Stavelin A; Flesche K; Tollaanes M; Christensen NG; Sandberg S
    Clin Chem Lab Med; 2020 Mar; 58(4):588-596. PubMed ID: 31821164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are general practitioners characteristics associated with the quality of type 2 diabetes care in general practice? Results from the Norwegian ROSA4 study from 2014.
    Tran AT; Bakke Å; Berg TJ; Gjelsvik B; Mdala I; Nøkleby K; Shakil Rai A; Cooper JG; Claudi T; Løvaas K; Thue G; Sandberg S; Jenum AK
    Scand J Prim Health Care; 2018 Jun; 36(2):170-179. PubMed ID: 29717939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postanalytical external quality assessment of blood glucose and hemoglobin A1c: an international survey.
    Skeie S; Perich C; Ricos C; Araczki A; Horvath AR; Oosterhuis WP; Bubner T; Nordin G; Delport R; Thue G; Sandberg S
    Clin Chem; 2005 Jul; 51(7):1145-53. PubMed ID: 15976099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between physicians' self-reported target fasting blood glucose levels and metabolic control in type 2 diabetes. The QuED Study Group--quality of care and outcomes in type 2 diabetes.
    Belfiglio M; De Berardis G; Franciosi M; Cavaliere D; Di Nardo B; Greenfield S; Kaplan SH; Pellegrini F; Sacco M; Tognoni G; Valentini M; Nicolucci A; Caimi V; Capani F; Corsi A; Della Vedova R; Massi Benedetti M; Nicolucci A; Taboga C; Tombesi M; Vespasiani G;
    Diabetes Care; 2001 Mar; 24(3):423-9. PubMed ID: 11289462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of improved HbA1c testing by primary care physicians.
    Flanders WD; Presley R; McClellan WM
    J Health Care Poor Underserved; 2005 Nov; 16(4):720-33. PubMed ID: 16311494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes - A feasibility study.
    Risøy AJ; Kjome RLS; Sandberg S; Sølvik UØ
    PLoS One; 2018; 13(2):e0191316. PubMed ID: 29474501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality Control of Norwegian Pharmacy HbA1c Testing: A Modest Beginning.
    Ørvim Sølvik U; Risøy AJ; Kjome RLS; Sandberg S
    J Diabetes Sci Technol; 2018 Jul; 12(4):753-761. PubMed ID: 29619895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of same-visit HbA1c test with laboratory-based measurements: a MetroNet study.
    Schwartz KL; Monsur JC; Bartoces MG; West PA; Neale AV
    BMC Fam Pract; 2005 Jul; 6():28. PubMed ID: 16014170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in HbA1c prescription for patients with diabetes in French general practice: an observational study prior to the implementation of a P4P programme.
    Chauvel N; Le Vaillant M; Pelletier-Fleury N
    Eur J Public Health; 2013 Feb; 23(1):61-6. PubMed ID: 22219502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HbA1c-mapping--evaluation of a new method for population-based monitoring of metabolic control in patients with diabetes mellitus].
    Sämann A; Lehmann T; Seeliger S; Kaiser J; Wolf G; Müller UA
    Gesundheitswesen; 2009 Aug; 71(8-9):476-80. PubMed ID: 19431107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in Point-of-Care Testing of HbA1c in Diabetes Care in General Practice.
    Kristensen T; Waldorff FB; Nexøe J; Skovsgaard CV; Olsen KR
    Int J Environ Res Public Health; 2017 Nov; 14(11):. PubMed ID: 29120361
    [No Abstract]   [Full Text] [Related]  

  • 14. Consequences of bias and imprecision in measurements of glucose and hba1c for the diagnosis and prognosis of diabetes mellitus.
    Petersen PH; Jørgensen LG; Brandslund I; De Fine Olivarius N; Stahl M
    Scand J Clin Lab Invest Suppl; 2005; 240():51-60. PubMed ID: 16112960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing diabetes mellitus: performance of hemoglobin A1c point-of-care instruments in general practice offices.
    Sølvik UØ; Røraas T; Christensen NG; Sandberg S
    Clin Chem; 2013 Dec; 59(12):1790-801. PubMed ID: 23958846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvements in diabetic care as measured by HbA1c after a physician education project.
    Deichmann RE; Castello E; Horswell R; Friday KE
    Diabetes Care; 1999 Oct; 22(10):1612-6. PubMed ID: 10526723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of an HbA1c tracking tool on primary care management of diabetes mellitus: glycaemic control, clinical practice and usability.
    Howard JA; Sommers R; Gould ON; Mancuso M
    Inform Prim Care; 2009; 17(1):41-6. PubMed ID: 19490772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical usefulness of glucated haemoglobin in diabetes care evaluated by use of a medical technology assessment strategy.
    Larsen ML
    Dan Med Bull; 1997 Jun; 44(3):303-15. PubMed ID: 9233549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HbA
    Kenealy T; Herd G; Musaad S; Wells S
    Prim Care Diabetes; 2019 Apr; 13(2):170-175. PubMed ID: 30545795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-care glucose and hemoglobin A1c in emergency department patients without known diabetes: implications for opportunistic screening.
    Ginde AA; Cagliero E; Nathan DM; Camargo CA
    Acad Emerg Med; 2008 Dec; 15(12):1241-7. PubMed ID: 18785943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.